|
|
|
| This article has been cited by | | 1 | CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway | | | Rui-Ying Wang,Xiao-Wei Chen,Wen-Wen Zhang,Fei Jiang,Meng-Qi Liu,Xiao-Bing Shen | | Molecular Medicine Reports.2019;() | | [DOI] | | | 2 | Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid | | | Christopher Trent Brewer,Kiran Kodali,Jing Wu,Timothy I. Shaw,Junmin Peng,Taosheng Chen | | Cells.2020;9(7)1654 | | [DOI] | | | 3 | CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis | | | Marty Richardson,Jamie Kirkham,Kerry Dwan,Derek J. Sloan,Geraint Davies,Andrea L. Jorgensen | | Systematic Reviews.2018;7(1)1654 | | [DOI] | |
|
